Results 91 to 100 of about 1,633 (196)

Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for rare gynecologic indications

open access: yes, 2020
\(\bf Background\) Peritoneal metastasis (PM) in patients with breast (BC) and endometrial cancer (EC) is rare and treatment options are limited. Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) has demonstrated efficacy against PM from various ...
Pabst, Urs (Dr. med.)   +3 more
core   +1 more source

Feasibility and Safety of Pressurized Intraperitoneal Aerosol Chemotherapy for Peritoneal Carcinomatosis: A Retrospective Cohort Study

open access: yesGastroenterology Research and Practice, 2017
Background. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) has been introduced as a novel repeatable treatment for peritoneal carcinomatosis.
Martin Hübner   +6 more
doaj   +1 more source

RNA expression profiling of peritoneal metastasis from pancreatic cancer treated with Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC)

open access: yesPleura and Peritoneum
Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) is an experimental treatment option in peritoneal metastasis from pancreatic cancer (PM-PC).
Detlefsen Sönke   +7 more
doaj   +1 more source

Combined Nabpaclitaxel pressurized intraPeritoneal aerosol chemotherapy with systemic Nabpaclitaxel-Gemcitabine chemotherapy for pancreatic cancer peritoneal metastases: protocol of single-arm, open-label, phase II trial (Nab-PIPAC trial)

open access: yesPleura and Peritoneum
Current therapies show limited efficacy against peritoneal metastases (PM) from pancreatic cancer. Pressurized intra-peritoneal aerosol chemotherapy (PIPAC) has emerged as a novel intraperitoneal drug delivery method.
Di Giorgio Andrea   +10 more
doaj   +1 more source

Research progress in clinical trials of pressurized intraperitoneal aerosol chemotherapy for advanced gastric cancer with peritoneal metastasis

open access: yesHolistic Integrative Oncology
Peritoneal metastasis is a common form of metastasis in advanced gastric cancer, often associated with poor prognosis. The distinctive biological characteristics of peritoneal metastasis have resulted in the limited efficacy of conventional treatments ...
Zifeng Yang   +3 more
doaj   +1 more source

Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for pancreatic cancer peritoneal metastases: A retrospective multicentric study from the ISSPP PIPAC Database

open access: yesEuropean Journal of Surgical Oncology
Pancreatic ductal adenocarcinoma (PDAC) is among the most aggressive malignancies, and peritoneal metastases (PM) represent the second most common site of dissemination, carrying a particularly poor prognosis. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is an emerging locoregional approach for intraperitoneal drug delivery.
Andrea Di Giorgio   +11 more
openaire   +3 more sources

The effect of pressurized intraperitoneal aerosolized chemotherapy on the surgical treatment outcomes of ovarian cancer with peritoneal carcinomatosis

open access: yesИсследования и практика в медицине
The development of new local treatment methods of peritoneal carcinomatosis in ovarian cancer is an urgent task due to the fact that in most cases complete surgical cytoreduction is technically impossible, and systemic cytostatic therapy does not provide
A. S. Dzasochov   +5 more
doaj   +1 more source

II.g) PIPAC [PDF]

open access: yesPleura and Peritoneum, 2018
openaire   +1 more source

Qualité de vie et résultat à court terme après chimiothérapie intra- Peritoneale vaporisée (PIPAC) chez les patients atteints de carcinose péritonéale.

open access: yes, 2017
Background. Peritoneal cancer treatment aims to prolong survival, but preserving Quality of Life (QoL) under treatment is also a priority. Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) is a novel minimally invasive repeatable treatment ...
TEIXEIRA FARINHA, Hugo
core  

Home - About - Disclaimer - Privacy